Matches in Wikidata for { <http://www.wikidata.org/entity/Q90927850> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q90927850 description "article scientifique publié en 2019" @default.
- Q90927850 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90927850 description "bài báo khoa học" @default.
- Q90927850 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90927850 description "scientific article published on 22 October 2019" @default.
- Q90927850 description "wetenschappelijk artikel" @default.
- Q90927850 description "наукова стаття, опублікована 22 жовтня 2019" @default.
- Q90927850 name "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 name "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 type Item @default.
- Q90927850 label "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 label "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 prefLabel "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 prefLabel "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 P1433 Q90927850-0B8C5F8F-BD07-4863-B3A9-C11BECDB6BBD @default.
- Q90927850 P1476 Q90927850-B735220A-9842-4EAC-852E-862E54D58061 @default.
- Q90927850 P2093 Q90927850-0127EF72-A5D1-4BAC-B1A3-84B11AFC1496 @default.
- Q90927850 P2093 Q90927850-7B203AC3-69DD-45DE-8BD2-A4979510DB72 @default.
- Q90927850 P2093 Q90927850-93FB5BC5-7786-4950-93B5-E5C2E4FE2694 @default.
- Q90927850 P2093 Q90927850-963031AC-B6A4-4A6B-94D0-6602A492850A @default.
- Q90927850 P2093 Q90927850-9BA6A0D0-AA41-4C24-8AE2-4D5DAABEA76B @default.
- Q90927850 P304 Q90927850-3646D3E1-2B63-4BF4-AE1C-0792EB377889 @default.
- Q90927850 P31 Q90927850-F60A84C4-2499-4EB6-99A7-19EE375E7FDA @default.
- Q90927850 P356 Q90927850-9C2363EB-74CC-4D1A-BD77-59F4A2A985FA @default.
- Q90927850 P433 Q90927850-2574F92F-A5AF-46E9-BFF0-A158E003DE08 @default.
- Q90927850 P478 Q90927850-6A083EAF-CE66-4BBC-A8E6-971F996BF57E @default.
- Q90927850 P50 Q90927850-70FDD847-C2FE-4A4D-B031-57040C2CA06C @default.
- Q90927850 P577 Q90927850-544D3EC9-2E0C-4E2B-A099-482F1A6ADD71 @default.
- Q90927850 P698 Q90927850-02C0BA95-0C9C-4787-B0BE-C6667DC1E06C @default.
- Q90927850 P921 Q90927850-74A4DFD6-9180-4832-A615-CD77C5A7C46A @default.
- Q90927850 P356 J.DLD.2019.09.012 @default.
- Q90927850 P698 31648920 @default.
- Q90927850 P1433 Q15766194 @default.
- Q90927850 P1476 "Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease" @default.
- Q90927850 P2093 "Camille Zallot" @default.
- Q90927850 P2093 "Francis Guillemin" @default.
- Q90927850 P2093 "Laurent Peyrin-Biroulet" @default.
- Q90927850 P2093 "Vincent Haghnejad" @default.
- Q90927850 P2093 "Yoann Dominique" @default.
- Q90927850 P304 "281-288" @default.
- Q90927850 P31 Q13442814 @default.
- Q90927850 P356 "10.1016/J.DLD.2019.09.012" @default.
- Q90927850 P433 "3" @default.
- Q90927850 P478 "52" @default.
- Q90927850 P50 Q90565531 @default.
- Q90927850 P577 "2019-10-22T00:00:00Z" @default.
- Q90927850 P698 "31648920" @default.
- Q90927850 P921 Q917447 @default.